PAT-GALANTAMINE ER

Identification of Pat-Galantamine Er

No description

Google image searchProduct monograph

Active ingredient

galantamine (galantamine hydrobromide), 8 MG

DIN: 02316943

Dosage form(s): CAPSULE (EXTENDED RELEASE)

Route(s) of administration: ORAL

Schedule: Prescription

Company: JANSSEN INC

Date: 20-JUL-2020

ATC:

• N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
• N06D — ANTI-DEMENTIA DRUGS (ATC, ATC/DDD)
• N06DA — Anticholinesterases (ATC, ATC/DDD)
• N06DA04 — GALANTAMINE (ATC/DDD)

Reference brand drug: Reminyl

Pharmaceutical standard: MFR

External Links for Pat-Galantamine Er

Search on Google

• Pat-Galantamine Er side effects
• Pat-Galantamine Er dosage
• galantamine side effects
• galantamine dosage

Janssen Inc

Go to Janssen website to see drug product details. Sometimes you can find pat-galantamine er photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.